| 发明名称 |
Opioid Antagonist Formulations |
| 摘要 |
In certain embodiments, the present invention is directed to a solid controlled-release dosage form comprising a core comprising a core portion of an opioid antagonist and a shell encasing the core and comprising a shell portion of the opioid antagonist, wherein the release profile of the core portion of opioid antagonist is different than the release profile of the shell portion of opioid antagonist. |
| 申请公布号 |
US2016243107(A1) |
申请公布日期 |
2016.08.25 |
| 申请号 |
US201415030709 |
申请日期 |
2014.12.22 |
| 申请人 |
PURDUE PHARMA L.P. |
发明人 |
Moline Margaret |
| 分类号 |
A61K31/485;A61K9/24;A61K9/20 |
主分类号 |
A61K31/485 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A solid controlled-release dosage form comprising a core comprising a core portion of an opioid antagonist and a shell encasing the core and comprising a shell portion of the opioid antagonist, wherein a release profile of the core portion of opioid antagonist is different than the release profile of the shell opioid antagonist. |
| 地址 |
Stamford CT US |
